Philip Watson

423 total citations
10 papers, 311 citations indexed

About

Philip Watson is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Philip Watson has authored 10 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Philip Watson's work include Synthesis and properties of polymers (1 paper), Blood properties and coagulation (1 paper) and Glycosylation and Glycoproteins Research (1 paper). Philip Watson is often cited by papers focused on Synthesis and properties of polymers (1 paper), Blood properties and coagulation (1 paper) and Glycosylation and Glycoproteins Research (1 paper). Philip Watson collaborates with scholars based in United Kingdom, Australia and Italy. Philip Watson's co-authors include Louise H. Naylor, L. Dembo, Conor Murray, Keith George, David Oxborough, Howard H. Carter, Daniel J. Green, Angela L. Spence, Anthony P. Weetman and Mabrouka Maamra and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Physiology and Scientific Reports.

In The Last Decade

Philip Watson

9 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Watson United Kingdom	6	149	70	45	43	42	10	311
Amato Santoro Italy	10	258 1.7×	44 0.6×	76 1.7×	35 0.8×	25 0.6×	34	376
MJ Drinkhill United Kingdom	10	110 0.7×	29 0.4×	10 0.2×	14 0.3×	40 1.0×	15	290
Jrg Kuipers Netherlands	9	82 0.6×	18 0.3×	9 0.2×	6 0.1×	34 0.8×	23	349
A. Campbell United Kingdom	9	136 0.9×	5 0.1×	27 0.6×	12 0.3×	12 0.3×	15	351
Antonio Fazi Italy	9	175 1.2×	7 0.1×	22 0.5×	18 0.4×	7 0.2×	26	350
Clara Bambace Italy	11	192 1.3×	7 0.1×	21 0.5×	7 0.2×	10 0.2×	12	500
Reinder Evertz Netherlands	11	576 3.9×	18 0.3×	89 2.0×	79 1.8×	4 0.1×	40	767
Abdullah Sökmen Türkiye	14	346 2.3×	13 0.2×	72 1.6×	2 0.0×	10 0.2×	35	484
Ede Birtalan Hungary	9	156 1.0×	39 0.6×	17 0.4×	3 0.1×	4 0.1×	12	323
Ki-Won Oh South Korea	11	75 0.5×	7 0.1×	10 0.2×	7 0.2×	6 0.1×	17	306

Countries citing papers authored by Philip Watson

Since Specialization

Citations

This map shows the geographic impact of Philip Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Watson more than expected).

Fields of papers citing papers by Philip Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Watson. The network helps show where Philip Watson may publish in the future.

Co-authorship network of co-authors of Philip Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Watson. A scholar is included among the top collaborators of Philip Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Watson. Philip Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Dembo, L., Philip Watson, Karen Wallman, et al.. (2019). Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy. Cardio-Oncology. 5(1). 11–11. 5 indexed citations

Lortat‐Jacob, Hugues, Alessandra Scarpellini, Nina Schroëder, et al.. (2016). Interplay between transglutaminases and heparan sulphate in progressive renal scarring. Scientific Reports. 6(1). 31343–31343. 18 indexed citations

Spence, Angela L., Louise H. Naylor, Howard H. Carter, et al.. (2011). A prospective randomised longitudinal MRI study of left ventricular adaptation to endurance and resistance exercise training in humans. The Journal of Physiology. 589(22). 5443–5452. 163 indexed citations

Anderson, J. M., et al.. (2007). 33.2: New Back Reflector and Front Film for Improved Efficiency of Direct‐lit LED Backlights for LCD TV. SID Symposium Digest of Technical Papers. 38(1). 1236–1239. 2 indexed citations

Zarkesh‐Esfahani, Sayyed Hamid, Zida Wu, Mabrouka Maamra, et al.. (2006). Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. Journal of Immunological Methods. 312(1-2). 190–200. 54 indexed citations

Metcalfe, Russell, Nicola Jordan, Philip Watson, et al.. (2002). Demonstration of Immunoglobulin G, A, and E Autoantibodies to the Human Thyrotropin Receptor Using Flow Cytometry. The Journal of Clinical Endocrinology & Metabolism. 87(4). 1754–1761. 40 indexed citations

Watson, Philip, et al.. (2001). LC3D : liquid crystal 3-D director simulator : software and technology guide. 3 indexed citations

Anderson, James E., Philip Watson, & Philip J. Bos. (2001). Study of relaxations in cholesteric liquid crystals after reduction of an electric field. Liquid Crystals. 28(6). 945–968. 5 indexed citations

Watson, Philip, et al.. (1998). Somatic hypermutation in antoimmune thyroid disease. Immunological Reviews. 162(1). 219–231. 21 indexed citations

10.

Watson, Philip. (1972). DO WE NEED A TAX LIMIT?. National Tax Journal. 25(3). 397–403.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact